• Pneumococcal
  • Recommendations for Adults

How did the ACIP recommendation for vaccination of smokers age 19 through 64 change in 2022?

In the pneumococcal vaccine recommendations for adults that were updated January 28, 2022, the many risk groups for pneumococcal disease were combined into one group with respect to vaccine recommendations. All are now recommended to receive PCV20 or PCV21 alone or PCV15 followed by PPSV23 one year later. ACIP no longer recommends the use of PPSV23 alone for any adult. Cigarette smokers age 19 through 64 who received PPSV23 in the past may now receive a dose of any recommended pneumococcal conjugate vaccine option (PCV15, PCV20, or PCV21) at least one year after their dose of PPSV23.

Last reviewed: August 8, 2024

This page was updated on .